T cell receptor alpha variable 34 (TRAV34)

The T cell receptor alpha variable 34 is a protein coding gene segment that encodes a variable domain of the TCR alpha chain, essential for the adaptive immune response. TRAV34 participates in antigen recognition by forming the variable region of the TCR that binds antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. This interaction initiates a signaling cascade critical for the activation, proliferation, and differentiation of T cells. The diversity of antigen recognition is generated through DNA recombination involving variable (V), joining (J), and constant (C) segments. TRAV34 is one of many TRAV segments that contribute to the vast diversity of the TCR repertoire. Aberrant use or mutation of TRAV segments is implicated in immune dysregulation, autoimmunity, and lymphoid malignancy. There are currently no drugs that directly target TRAV34, but TCR variable regions (including TRAV34) are of interest in immunotherapy, biomarker development, and immune repertoire sequencing

Other names

TCRAV26S1TCRAV34S1TRAV34T cell receptor alpha variable 34

No direct drug mechanisms for this specific segment; general TCR-directed cell therapies work by engineered antigen recognition and immune activation